Articles On Telix Pharmaceuticals (ASX:TLX)

I think the healthcare sector is a great place to look for buy and hold options. This is because in this sector you’ll find a number of companies that have the potential to grow significantly in the future thanks to favourable tailwinds an...

03 Sep 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a strategic collaboration agreement with California-based Varian Medical Systems.

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record another strong gain. At the time of writing the benchmark index is up 1% to 6,121.7 points. Four shares that are climbing more than most today are listed below....

Jobkeeper subsidies will make up two thirds of dental group 1300 Smiles’ (ASX:ONT) final dividend at 12.5c payout. The company has maintained its fully franked final dividend at 12.5c, paying out a total of $2.96m to investors. The company...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The pundit...

One area of the share market which I believe is home to a number of promising small caps is the healthcare sector. Thanks to positive tailwinds and their impressive technology and products, I believe there are companies at this side of the...

It has been a busy day of quarterly update releases on the Australian share market. And while the likes of Bubs Australia Ltd (ASX: BUB) and Sezzle Inc (ASX: SZL) may have stolen the headlines, they weren’t the only companies releasing upd...

Telix Pharmaceuticals (ASX:TLX) says it has entered into a strategic collaboration agreement with US-based RefleXion Medical.

Pharmaceutical company Althea Group (ASX:AGH) had some interesting distribution news, announcing the Australian-first launch of an online channel for its medicinal cannabis products. The company says its Althea Concierge service, which has...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Victoria h...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has jumped by 16.02% today on the back of a market announcement released this morning. The announcement confirmed the company has received a ‘Breakthrough Therapy’ (BT) designation for i...

01 Jul 2020 - Telix Pharmaceuticals (ASX:TLX) reports that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy (BT) designation for Telix’s renal cancer imag…

The S&P/ASX 200 Index (ASX: XJO) is on course to start the new financial year with a solid gain. At the time of writing the benchmark index is up 0.65% to 5,936.2 points. Four shares that have climbed more than most today are listed be...

Clinical-stage biopharmaceutical company Telix Pharmaceuticals (ASX: TLX) has received confirmation from the FDA that its kidney cancer imaging product TLX250-CDx had been granted breakthrough therapy (BT) designation. The company claims to...

ShareCafeHidden Gems Webinar Recap – MMM, NCZ, ALC, TLX We continue to unearth micro and small-cap companies as part of our Hidden Gems webinar series. Catch up on the most recent edition with presentations from Marley Spoon AG (ASX:MMM), N...

Telix Pharmaceuticals (US) Inc, a subsidiary of Telix Pharmaceuticals Limited (ASX: TLX) announced on Friday that it has entered into a commercial distribution agreement with Boca Raton-based Pharmalogic Holdings Corp. (Pharmalogic) to prov...

15 May 2020 - Telix Pharmaceuticals (ASX:TLX) has entered into a commercial distribution agreement with Boca Raton-based Pharmalogic.

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on watch this morning following an announcement that it has received a major research grant for the development of drugs for a range of cancers. At the time of writing, Telix shares a...

The market carnage is certainly proving a great buying opportunity for directors, with even more last week, compared to the week before, scrambling to top up their holdings. Stockhead found 19 directors trades over $100,000 among ASX small...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is trading slightly higher on Tuesday after the release of a positive update. At the time of writing the clinical-stage biopharmaceutical company’s shares are up 0.5% to $1.52. This comp...

Jumbo Interactive (ASX:JIN) has added MS (Multiple Sclerosis) Queensland to its cohort of charity lottery clients. MS Queensland has bought a five-year licence for Jumbo’s online lottery software-as-a-service (SaaS) to set up a customised s...

Telix Pharmaceuticals (TLX) has received approval from the U.S. Food and Drug Administration for the ZIRCON study The ZIRCON study is an international Phase III study to evaluate the utility of Telix’s product which treats clear cell rena...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has been a strong performer on Thursday. In morning trade the clinical-stage biopharmaceutical company’s shares are up 3.5% to $1.50. Why is the Telix Pharmaceuticals share price chargin...

You may have heard the saying “it’s not brain surgery” in the context of trying to prove something easy. Well there is a reason  — our brains are among the most difficult parts of our body to treat. There are a few ASX small caps trying to...

The health sector was the most successful sector on the ASX in 2019. Various small caps made several breakthroughs including with nerve damage and macular degeneration. While cancer remains one fish that has yet to be fried there are small...

Telix Pharmaceuticals (TLX) has submitted a clinical briefing package to the U.S. FDA for its prostate cancer treating drug The company has also completed the additional manufacturing and product release analytics that were recommended by...

Telix Pharmaceuticals (TLX) has submitted a phase 3 Investigational New Drug application to the U.S. FDA for its antibody-based imaging agent This applications forms part of the international phase 3 ZIRCON study which is expected to begi...

Invion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. The company told shareholders this morning it signed an MoU with Pavay Biotech, an established provider of dermatology treatment products in...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is pushing higher in morning trade. At the time of writing the clinical-stage biopharmaceutical company’s shares are up almost 2.5% to $1.54. Today’s gain means that Telix’s shares are n...

I wanted to take this opportunity, on behalf of the whole team here at The Motley Fool, to wish all of our members and readers a very Merry Christmas. There are plenty of other places to go for investment advice. We’re humbled that you’ve...

ASX pharma group Telix Pharmaceuticals Ltd (ASX: TLX) is one company worth watching this morning. The Telix share price could climb higher after receiving a research grant from Cancer Australia yesterday. What did Telix announce yesterday?...

20 Dec 2019 - Biopharmaceutical company, Telix Pharmaceuticals (ASX:TLX) is pleased to announce that Telix collaborator Professor Frédéric Hollande has been awarded a research gran…

Pharmaxis (ASX:PXS) has some big news from its German partner, but won’t yet say whether it’s good or bad. The company has been waiting on pharmaceutical major Boehringer Ingelheim to decide whether it wants to go ahead and further develop...

On 2 December 2019, the S&P/ASX 200 Health Care Sector (XHJ) traded higher at 42,106.3 points, with a rise of 0.83% compared to the last close. The S&P/ASX 200 Index traded at 6,862.3 points, up by 0.24% from its previous close. YT...

Drug Development Process The drug development process starts from drug discovery and ends at the launch of the new pharmaceutical product in the market. The process includes drug discovery and development, preclinical trials, clinical trial...

One of the oldest tropes in journalism is the miracle cure. Startup Daily is old enough to remember when Filipino faith healers were all the rage in the 1980s – think Penn & Teller meets House. More recently, there was US blood-testing...

There are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so — but less than 25 are anywhere close to their ultimate dream of bringing a drug successfully to market, a Stockhead analysis has found. Ta...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has dropped lower with the market on Wednesday. In afternoon trade the pharmaceutical company’s shares are down 1% to $1.61 despite the release of a positive announcement. What did Telix...

See our brand new top 10 broker reviews. Find your perfect platform! Tom Bleakley, BW Equities BUY RECOMMENDATIONS Telix Pharmaceuticals (TLX) Chart: Share price over the year TLX is a clinical stage biopharmaceutical company, focusing on d...

One area of the market that I think is a good place to look for buy and hold options is the small end of the healthcare sector. I think here you’ll find a number of companies that have the potential to grow significantly in the future than...

07 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) today announced that Dr David Cade has joined the Telix executive leadership team in the role of Chief Business Officer and Head of In…

Telix Pharmaceuticals Limited (ASX: TLX) has entered into conditional purchase agreement with Eckert & Ziegler Strahlen und Medizintechnik Aktiengesellschaft to acquire a licensed radiopharmaceutical production facility in Seneffe, Belg...

The Telix Pharmaceuticals Ltd  (ASX: TLX) share price is one to watch in early trade after the company announced a new market acquisition this morning. What did Telix Pharmaceuticals announce? Telix announced that it has entered into a con...

03 Oct 2019 - Telix Pharmaceuticals (ASX:TLX) has entered into a conditional purchase agreement with technology giant Eckert & Ziegler to acquire a radiopharmaceutical production f…

Health care industry Australian health care industry is not just on a strong growth path but also competes on the global scale. Health Care comprises of a dynamic sector including pharmaceuticals, medical devices, health insurance and hospi...

Imagion Biosystems: Breakthrough Device By Pitt Street Research An innovative medical device company   Imagion Biosystems ((IBX)) is an Australian medical device company whose MagSense diagnostic imaging technology, currently in early stage...

ASX code: IBX Market cap: $12.95m Share price: 4c Shares on issue: 323,705,324 Chairman and CEO: Bob Proulx Board*: Bob Proulx, Michael Harsh, Jovanka Naumoska, Bronwyn Le Grice, Mark Van Asten, David Ludvigson *Dr John Hazle resigned in la...

One area of the share market which I think has strong long term growth potential is the healthcare sector. This is due to ageing populations, increased chronic disease burden, population growth, and technological advances to name just four...